These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 23552643

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Conformational transitions and fibrillation mechanism of human calcitonin as studied by high-resolution solid-state 13C NMR.
    Kamihira M, Naito A, Tuzi S, Nosaka AY, Saitô H.
    Protein Sci; 2000 May; 9(5):867-77. PubMed ID: 10850796
    [Abstract] [Full Text] [Related]

  • 3. Characterization of the spherical intermediates and fibril formation of hCT in HEPES solution using solid-state 13C-NMR and transmission electron microscopy.
    Itoh-Watanabe H, Kamihira-Ishijima M, Kawamura I, Kondoh M, Nakakoshi M, Sato M, Naito A.
    Phys Chem Chem Phys; 2013 Oct 21; 15(39):16956-64. PubMed ID: 24002168
    [Abstract] [Full Text] [Related]

  • 4. Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy.
    Naito A, Kamihira M, Inoue R, Saitô H.
    Magn Reson Chem; 2004 Feb 21; 42(2):247-57. PubMed ID: 14745805
    [Abstract] [Full Text] [Related]

  • 5. A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone: a single beta-sheet model with a small hydrophobic core.
    Haspel N, Zanuy D, Ma B, Wolfson H, Nussinov R.
    J Mol Biol; 2005 Feb 04; 345(5):1213-27. PubMed ID: 15644216
    [Abstract] [Full Text] [Related]

  • 6. Molecular Insights into the Effects of F16L and F19L Substitutions on the Conformation and Aggregation Dynamics of Human Calcitonin.
    Huang F, Huang J, Yan J, Liu Y, Lian J, Sun Q, Ding F, Sun Y.
    J Chem Inf Model; 2024 Jun 10; 64(11):4500-4510. PubMed ID: 38745385
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Inhibiting Human Calcitonin Fibril Formation with Its Most Relevant Aggregation-Resistant Analog.
    Chen YT, Hu KW, Huang BJ, Lai CH, Tu LH.
    J Phys Chem B; 2019 Dec 05; 123(48):10171-10180. PubMed ID: 31692350
    [Abstract] [Full Text] [Related]

  • 12. Structural investigations of a human calcitonin-derived carrier peptide in a membrane environment by solid-state NMR.
    Wagner K, Beck-Sickinger AG, Huster D.
    Biochemistry; 2004 Oct 05; 43(39):12459-68. PubMed ID: 15449935
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Controlling the self-assembly of human calcitonin: a theoretical approach using molecular dynamics simulations.
    Paul S, Paul S.
    Phys Chem Chem Phys; 2021 Jul 07; 23(26):14496-14510. PubMed ID: 34184696
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Conformational analysis of human calcitonin in solution.
    Ogawa K, Nishimura S, Doi M, Takashima H, Nishi Y, Yoshida T, Ohkubo T, Kobayashi Y.
    J Pept Sci; 2006 Jan 07; 12(1):51-7. PubMed ID: 15948142
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity.
    Shang H, Zhou A, Jiang J, Liu Y, Xie J, Li S, Chen Y, Zhu X, Tan H, Li J.
    Acta Biomater; 2018 Sep 15; 78():178-188. PubMed ID: 30076991
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.